Breckenridge launches Tofacitinib Tablets, generic equivalent to Pfizer's Xeljanz

Hims & Hers expands GLP-1 offering in Canada with generic semaglutide

Apotex announces commercial launch of Apo-Semaglutide Injection in Canada

Transpire Bio's generic high-strength Trelegy Ellipta ANDA accepted for filing by US FDA

Kaiser Permanente reports study findings showing significant cost savings

Apotex receives Health Canada approval for a generic Ozempic equivalent

Cipla's AB-rated Ventolin HFA generic receives US FDA approval

Newbury Pharmaceuticals secures first Scandinavian approval for palbociclib generic

Apotex's generic Ozempic (Semaglutide Injection) receives US FDA tentative approval

DifGen and Apotex report FDA approval of generic Nintedanib Soft Gel Capsules

Dexcel Pharma's Nintedanib Capsules approved for US launch

Upsher-Smith launches generic version of Ciprodex ear drop suspension

Parnell launches first FDA-approved generic florfenicol and flunixin combination for bovine respiratory disease

Samsung Bioepis partners with Sandoz on up to five next-generation biosimilars

Breckenridge Pharmaceutical partners with sterile injectable manufacturer Maiva Pharma